UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

How to Monitor the Neuroimmune Biological Response in Patients Affected by Immune Alteration-Related Systemic Diseases

Methods in molecular biology (Clifton, N.J.), 2018, Vol.1781, p.171

2018

Link zum Volltext

Verfügbarkeit prüfen

Neuroimmunomodulation in Medical Oncology: Application of Psychoneuroimmunology with Subcutaneous Low-dose IL-2 and the Pineal Hormone Melatonin in Patients with Untreatable Metastatic Solid Tumors

Anticancer research, 2008-03, Vol.28 (2B), p.1377-1381

2008

Link zum Volltext

Verfügbarkeit prüfen

Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status

European journal of cancer (1990), 1999-11, Vol.35 (12), p.1688-1692

1999

Link zum Volltext

Verfügbarkeit prüfen

Anti-angiogenic activity of melatonin in advanced cancer patients

Neuro-endocrinology letters, 2001, Vol.22 (1), p.45-47

2001

Link zum Volltext

Verfügbarkeit prüfen

Evidence of pineal endocrine hypofunction in autistic children

Neuro-endocrinology letters, 2000, Vol.21 (1), p.31-34

2000

Link zum Volltext

Verfügbarkeit prüfen

Is there a role for melatonin in the treatment of neoplastic cachexia?

European journal of cancer (1990), 1996-07, Vol.32 (8), p.1340-1343

1996

Link zum Volltext

Verfügbarkeit prüfen

Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study

Journal of pineal research, 1999-04, Vol.26 (3), p.169-173

1999

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies

Anticancer research, 2000-05, Vol.20 (3B), p.2103

2000

Link zum Volltext

Verfügbarkeit prüfen

Abrogation of the Negative Influence of Opioids on IL–2 Immunotherapy of Renal Cell Cancer by Melatonin

European urology, 2000-07, Vol.38 (1), p.115-118

2000

Link zum Volltext

Verfügbarkeit prüfen

A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state

Journal of pineal research, 1997-08, Vol.23 (1), p.15-19

1997

Link zum Volltext

Verfügbarkeit prüfen

A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia

Neuro-endocrinology letters, 2001-04, Vol.22 (2), p.137-141

2001

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma

Journal of pineal research, 1996-11, Vol.21 (4), p.239-242

1996

Link zum Volltext

Verfügbarkeit prüfen

Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin

Supportive care in cancer, 1997-03, Vol.5 (2), p.126-129

1997

Link zum Volltext

Verfügbarkeit prüfen

Circadian Secretions of IL-2, IL-12, IL-6 and IL-10 in Relation to the Light/Dark Rhythm of the Pineal Hormone Melatonin in Healthy Humans

Natural immunity, 1998-01, Vol.16 (1), p.1-5

1998

Link zum Volltext

Verfügbarkeit prüfen

Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system

Neuro-endocrinology letters, 2002-08, Vol.23 (4), p.341-344

2002

Link zum Volltext

Verfügbarkeit prüfen

Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone

European urology, 1997, Vol.31 (2), p.178

1997

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha

In vivo (Athens), 2002-03, Vol.16 (2), p.93

2002

Link zum Volltext

Verfügbarkeit prüfen

Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia

Journal of pineal research, 2001-03, Vol.30 (2), p.123-126

2001

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients

British journal of cancer, 1996-11, Vol.74 (9), p.1466-1468

1996

Link zum Volltext

Verfügbarkeit prüfen

Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study

Neuro-endocrinology letters, 2003-06, Vol.24 (3-4), p.259-262

2003

Link zum Volltext

Verfügbarkeit prüfen

A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer

Tumori, 1994-12, Vol.80 (6), p.464

1994

Link zum Volltext

Verfügbarkeit prüfen

Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone

Neuro-endocrinology letters, 2000, Vol.21 (4), p.319-323

2000

Link zum Volltext

Verfügbarkeit prüfen

Melatonin as a new possible anti-inflammatory agent

Journal of biological regulators and homeostatic agents, 1997-10, Vol.11 (4), p.157

1997

Link zum Volltext

Verfügbarkeit prüfen

Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies

Oncology, 1991, Vol.48 (6), p.448

1991

Link zum Volltext

Verfügbarkeit prüfen

Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin

Journal of biological regulators and homeostatic agents, 1994-10, Vol.8 (4), p.126

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

ThemaMelatonin

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Female
(43)
Male
(43)
Middle Aged
(40)
Adult
(35)
Aged
(34)
Pineal Gland
(32)
Biological And Medical Sciences
(25)
Melatonin - Therapeutic Use
(24)
Endocrinology & Metabolism
(23)
Interleukin-2
(20)
Medical Sciences
(20)
Melatonin - Administration & Dosage
(18)
Oncology
(17)
Immunotherapy
(16)
Physiology
(16)
Interleukin-2 - Administration & Dosage
(15)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How to Monitor the Neuroimmune Biological Response in Patients Affected by Immune Alteration-Related Systemic Diseases

Neuroimmunomodulation in Medical Oncology: Application of Psychoneuroimmunology with Subcutaneous Low-dose IL-2 and the Pineal Hormone Melatonin in Patients with Untreatable Metastatic Solid Tumors

Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status

Anti-angiogenic activity of melatonin in advanced cancer patients

Evidence of pineal endocrine hypofunction in autistic children

Is there a role for melatonin in the treatment of neoplastic cachexia?

Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study

A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies

Abrogation of the Negative Influence of Opioids on IL–2 Immunotherapy of Renal Cell Cancer by Melatonin

A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state

A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia

Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma

Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin

Circadian Secretions of IL-2, IL-12, IL-6 and IL-10 in Relation to the Light/Dark Rhythm of the Pineal Hormone Melatonin in Healthy Humans

Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system

Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone

A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha

Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia

A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients

Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study

A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer

Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone

Melatonin as a new possible anti-inflammatory agent

Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies

Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin

Aktive Filter

Suchergebnisse filtern